New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Evaxion Biotech A/S
EVAX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

15M

Biotechnology

Next Earning date - 17 Dec 2024

15M

Biotechnology

Next Earning date - 17 Dec 2024

2.84USD
Shape0.10 ( 3.65%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-71%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

79%

Quote Panel

Shape
Updated October 29, 2024
1W 5.99 % 1M -9.00 % 3M 2.91 % 1Y -69.73 %

Key Metrics

Shape
  • Market Cap

    15.37M


  • Shares Outstanding

    5.41M


  • Share in Float

    35.14M


  • Dividende

    0


  • Earning Date

    17 Dec 2024


  • Price Target

    2.84


  • Average Volume

    48781


  • Beta

    -0.249


  • Range

    2.26-13.61


  • Industry

    Biotechnology


  • Website

    https://www.evaxion-biotech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

55.21x

P/S Ratio

12.26x

P/B Ratio

7.0

Debt/Equity

-5473.9%

Net Margin

$-4.5

EPS

How EVAX compares to sector?

P/E Ratio

Relative Strength

Shape

EVAX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$8M

Shape4909%

2025-Revenue

$0.27

Shape76%

2025-EPS

$5M

Shape202%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-2.40
vs -3.90

Q4.22

arrow
arrow

N/A

-0.39
vs -3.90

Q1.23

arrow
arrow

N/A

-2.40
vs -2.50

Q2.23

arrow
arrow

N/A

-2.10
vs -2.00

Q3.23

arrow
arrow

N/A

-2.10
vs NA

Q4.23

arrow
arrow

N/A

-0.16
vs -0.39

Q1.24

arrow
arrow

+101%

0.03
vs -2.40

Q2.24

arrow
arrow

N/A

-0.12
vs -2.10

Q3.24

arrow
arrow

N/A

-0.31
vs -2.10

Q4.24

arrow
arrow

N/A

-0.29
vs -0.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

73.6K  vs NA

Q1.24

arrow
arrow

NA

50.9K  vs NA

Q2.24

arrow
arrow

NA

153.9K  vs NA

Q3.24

arrow
arrow

NA

123.3K  vs NA

Q4.24

arrow
arrow

+59%

117.3K  vs 73.6K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+9%

0.09
vs -0.24

Q4.22

arrow
arrow

+9%

0.09
vs 0.09

Q1.23

arrow
arrow

+8%

0.08
vs 0.09

Q2.23

arrow
arrow

-224%

-2.24
vs 0.08

Q3.23

arrow
arrow

+6%

0.06
vs -2.24

Q4.23

arrow
arrow

+96%

0.96
vs 0.06

Q1.24

arrow
arrow

+46%

0.46
vs 0.96

Q2.24

arrow
arrow

-494%

-4.94
vs 0.46

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

14

14
vs 15

-7%

Q2.22

arrow
arrow

11

11
vs 14

-21%

Q3.22

arrow
arrow

9

9
vs 11

-18%

Q4.22

arrow
arrow

11

11
vs 9

22%

Q1.23

arrow
arrow

11

11
vs 11

NA

Q2.23

arrow
arrow

10

10
vs 11

-9%

Q3.23

arrow
arrow

11

11
vs 10

10%

Q4.23

arrow
arrow

10

10
vs 11

-9%

Earnings Growth

Latest News